Quick Summary
Covering the latest research from top Wall Street investment banks

Morgan Stanley believes the tightening of cross-border TRS for Chinese brokers is more like a risk-management measure

Institution
Morgan Stanley
Date
2026-06-24
Authors
Chiyao Huang, Richard Xu, CFA, Beryl Yang, Chenqian Liu
Company
-
Ticker
-
Industry
China Financials / Brokers
Rating
Attractive
NeutralLow confidenceThe report argues that the suspension of new cross-border TRS activity is more likely countercyclical window guidance based on risk exposure and compliance issues, rather than a comprehensive shift in the TRS regulatory framework; the expected incremental impact on derivatives ROE for leading brokers is limited.
AuthorsChiyao Huang, Richard Xu, CFA, Beryl Yang, Chenqian Liu
CoverageAsia-Pacific
Asset classesDerivatives
Business segmentsBroker derivatives business、Cross-border total return swaps、Southbound TRS、Northbound TRS
Research firm divisions/subsidiariesMorgan Stanley Asia Limited(Other)

AI summary card

Morgan Stanley believes the tightening of cross-border TRS for Chinese brokers is more like a risk-management measure

Regulators have suspended some new cross-border TRS demand, with the core intent likely to be managing risk exposure amid overseas equity volatility and reducing non-compliant structures; the expected incremental earnings impact on leading brokers is limited.

The industry view is Attractive; no new individual stock target prices or rating changes were provided.
China brokersCross-border TRSDerivatives businessRegulatory window guidanceRisk managementA-share hard technology
  • Some domestic private funds were informed by brokers that new cross-border total return swaps business would be suspended.
  • The report believes demand for southbound TRS has grown rapidly this year, mainly due to rising domestic private fund asset size and demand for exposure to overseas AI and technology stocks.
  • Morgan Stanley judges that the regulatory action looks more like countercyclical risk management under recently supportive derivatives rules, rather than a comprehensive shift in TRS regulation.
  • The expected impact on brokers is limited because regulators have restricted total broker derivatives scale since early 2024, and leading brokers may already be close to the cap.
  • With the total quota constraint still in place, brokers can redirect quota to northbound TRS and other derivatives to meet demand for A-share hard-technology names.

Report interpretation

Overview

This report is Morgan Stanley's commentary on the tightening of cross-border TRS for Chinese brokers. On June 24, STCN reported that some Chinese private funds had been notified by brokers that new cross-border total return swaps business would be suspended. The report believes this is mainly related to regulators managing increased risk exposure amid volatility in overseas equity markets, while it may also target non-compliant behavior in which some private funds help investors circumvent suitability requirements through specific structures.

Core views

The core view is that the tightening of cross-border TRS should be understood as risk management and countercyclical window guidance, rather than a fundamental shift in the TRS regulatory regime. Although derivatives business has recently been one of the growth drivers of ROE for leading brokers, the marginal impact of the suspension of new business is expected to be limited. Reasons include that regulators have capped the total size of brokers' derivatives books since early 2024, and most leading brokers may already be close to the limit; with the total quota unchanged, brokers can redirect capacity to northbound TRS and other derivatives, especially categories driven by growing demand for A-share hard technology.

Analysis framework

The report uses event-driven regulatory impact analysis: it first identifies the background triggering the suspension of new cross-border TRS activity, and then assesses the impact on Chinese brokers' earnings and industry momentum from four angles: regulatory motivation, compliance governance, caps on brokers' derivatives scale, and business substitution direction.

Methodology notes

  • Regulatory event analysisWindow Guidance and Risk Exposure Management Framework

    Viewing the suspension of new cross-border TRS activity as a countercyclical risk-management tool

    The report believes regulators may not be banning the TRS business itself, but rather using window guidance to control new risk while overseas equity volatility rises and private-fund southbound exposure grows rapidly.

  • Industry view frameworkMorgan Stanley Industry View

    Attractive

    Attractive means the analyst expects the covered industry to deliver attractive performance relative to the relevant broad market benchmark over the next 12-18 months.

  • Business substitution analysisDerivatives Quota Reallocation

    Shifting from southbound TRS to northbound TRS or other derivatives

    With caps on brokers' total derivatives scale still in place, suspending new southbound cross-border TRS does not necessarily lead to a proportional decline in total business volume, as brokers may redirect capacity toward demand related to A-share hard technology.

Asset mapping & comparison

Structured mapping from thesis to named assets (strengths, weaknesses, peers, risks).

  • Leading Chinese brokers
    The core asset group directly affected by the suspension of new cross-border TRS activity
    Strengths
    They have relatively strong derivatives capabilities, a solid customer-demand base, and can adjust allocations across different derivatives categories within the total quota.
    Weaknesses
    Restrictions on new cross-border TRS activity will weaken the conversion of some southbound exposure demand, and growth elasticity in the derivatives business is constrained by regulatory quotas.
    Comparison
    Compared with small and mid-sized brokers, leading brokers are more likely to already be near the cap on total derivatives scale, so the impact of restricted marginal new business may be more structural.
    Risks
    Further regulatory tightening, greater overseas equity market volatility, and stricter compliance reviews could weigh on business growth and valuation expectations.
  • Southbound TRS
    The direct target of this regulatory tightening
    Strengths
    It meets domestic private funds' demand for exposure to overseas AI and technology stocks, and demand has grown quickly this year.
    Weaknesses
    Its cross-border nature brings regulatory scrutiny around market volatility, leverage, and investor suitability.
    Comparison
    Compared with northbound TRS, southbound TRS is more directly exposed to overseas equity market volatility and cross-border compliance issues.
    Risks
    The suspension of new business may last longer, or expand into stricter reviews of quotas, client qualifications, and structures.
  • Northbound TRS / A-share hard-technology exposure
    A potential direction for quota transfer and business substitution
    Strengths
    Supported by rising demand for A-share hard-technology names and an increase in high-quality hard-technology IPOs.
    Weaknesses
    It is still constrained by caps on brokers' total derivatives scale and cannot fully escape regulatory capacity limits.
    Comparison
    Compared with southbound TRS, northbound TRS is more tied to domestic hard-technology asset demand and may absorb part of the business quota.
    Risks
    Volatility in A-share hard technology, changes in the IPO pace, and limits on total derivatives scale will affect the substitution room.

Key data

  • EventSome Chinese private funds were notified by brokers that new cross-border total return swaps business would be suspendedThe source is STCN's June 24 report, on which this event commentary is based.
  • Demand backgroundDemand for southbound TRS has grown rapidly this yearMainly alongside rising domestic private fund AUM and demand for exposure to overseas AI and technology stocks.
  • One regulatory reasonManaging increased risk exposure amid overseas equity market volatilityThe report believes the CSRC may want to control cross-border risks related to brokers and private funds.
  • A second regulatory reasonTightening some non-compliant structures that circumvent investor suitability requirementsSome private funds may use specific structures to help investors bypass qualification requirements.
  • Existing constraintRegulators have restricted the total size of brokers' derivatives books since early 2024The report believes most leading brokers are already close to the cap after the rebound in business in 2025 and year to date.
  • Substitution directionNorthbound TRS and demand for A-share hard-technology-related derivativesAs more high-quality hard-technology companies IPO on the A-share market, related attractiveness is expected to continue rising.
  • Industry viewAttractiveThe report's disclosed Asia Pacific Industry View / China Financials industry view.

Impact & implications

For Chinese brokers, the short-term impact is concentrated in restrictions on new cross-border southbound TRS business, but the marginal drag on overall derivatives revenue and ROE for leading brokers may be smaller than initial market concerns. A regulatory cap on total scale already exists, meaning the suspension of new business changes business mix more than it compresses the total business pie without limit. If the supply of A-share hard-technology assets continues to increase, northbound TRS or other domestic equity derivatives demand may become substitute growth drivers.

Risks

  • Greater overseas equity market volatility may prompt regulators to further strengthen cross-border risk management.
  • If regulation escalates from window guidance to clearer long-term restrictions, growth in brokers' derivatives business may come in below expectations.
  • If behavior by some private funds to circumvent investor suitability requirements through structures is further rectified, related customer demand may decline.
  • Caps on brokers' total derivatives scale limit room for business expansion, so even if demand for northbound TRS increases, it may still be constrained by quotas.
  • The report includes standard sell-side research conflict-of-interest disclosures, and investors should treat it as a single reference factor rather than an independent investment basis.

What to watch

  • Whether the CSRC subsequently issues formal rules or continues to manage cross-border TRS through window guidance.
  • The scope of implementation, duration, and client-type restrictions for brokers' suspension of new southbound TRS activity.
  • Whether leading brokers' derivatives book size is approaching or reaching the regulatory cap.
  • Whether northbound TRS and A-share hard-technology-related derivatives demand can absorb the constrained southbound TRS quota.
  • Whether volatility in overseas AI and technology stocks continues to affect domestic private funds' demand for cross-border exposure.
  • Changes in the contribution of derivatives business to Chinese brokers' subsequent ROE.
Zhejiang ICP No. 2022035445-5
Disclaimer: Market data, charts, indicators, research views, and other information provided on this website are intended solely for information display, research communication, and educational reference. They should not be regarded as personalized investment advice, securities recommendations, trading instructions, solicitations, or guarantees of return. While we strive to improve the reliability of our data and content, such information may still be subject to delays, errors, incompleteness, or untimely updates due to source differences, methodological limitations, system processing, or market volatility. Users should exercise independent judgment based on their own circumstances and bear all risks and responsibilities arising from the use of this website.

Settings

Sign in to view recent logins